Kumuda Company
A new approach to drug discovery
Technology:
Immunotherapy
Headquarters:
Boston, Massachusetts, United States
Last Funding Date:
2020-01-17
Total Funding:
120000.0
Last Funding Type:
Pre-Seed
Founded Date:
2020-01-01
Investors Number:
1.0
Industry:
Early Drug Development
Employee Number:
1-10
Estimated Revenue:
$1M to $10M
Funding Status:
Seed